secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0001683168-21-005860
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences enters $4M ATM equity offering with H.C. Wainwright
-----------------------------------------------------------------------

- Entered ATM Agreement with H.C. Wainwright as exclusive agent to sell up to $4M of common stock.
- Shares sold at-the-market on Nasdaq; Wainwright receives 3% commission on gross proceeds.
- Company has no obligation to sell any shares and may suspend or terminate the agreement.
- Agreement effective November 19, 2021; filed as Exhibit 1.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316821005860/0001683168-21-005860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316821005860/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-005860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer